Paper: Using PreciseInhale® for Controlled Volunteer Exposures with Aerosols Extracted from Clinical Inhalers
Eunice Costa
Eunice Costa joined Hovione in 2011 and currently leads the Inhalation and Advanced Drug Delivery area at Hovione, responsible for particle engineering, formulation design and device development for both conventional and engineered inhalation products, as well as biopharmaceuticals and new drug delivery modalities. Eunice holds a PhD in Bioengineering Systems from the MIT-Portugal program and has held positions as a researcher in organizations such as Genentech, Hovione and academia. Since joining Hovione, Eunice has been actively researching on the impact of particle engineering, particularly spray drying, formulation properties and processing on the performance and disposition of inhaled medicines and biologics.
Per Gerde
Per Gerde is an Associate Professor of Inhalation Toxicology, Institute of Environmental Medicine at the Karolinska Institutet, Stockholm, Sweden. Dr. Gerde is also Chief Scientific Officer at Inhalation Sciences Sweden AB. He received his doctoral degree at the Royal Institute of Technology in Stockholm and was a postdoctoral fellow at the Lovelace Respiratory Research Institute (1989–1991) Albuquerque, New Mexico. Previous appointments also include scientist at the Lovelace Respiratory Research Institute (1993– 1998), scientist at the Swedish National Institute of Occupational Health (1991–1996).
Dr. Gerde has published approximately 50 peer reviewed scientific papers. He is also the main inventor of six patent families with related patent applications. Major research interest has been the pulmonary pharmacokinetics of particle associated inhalants, and the development of aerosol exposure methods to validate kinetic models both in vitro and in vivo.